Kinetic characterization of protein arginine deiminase 4: A transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis

被引:167
作者
Kearney, PL
Bhatia, M
Jones, NG
Yuan, L
Glascock, MC
Catchings, KL
Yamada, M
Thompson, PR
机构
[1] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA
[2] Univ S Carolina, Nanoctr, Columbia, SC 29208 USA
[3] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan
关键词
D O I
10.1021/bi050292m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine deiminase 4 (PAD4) is a Ca2+-dependent enzyme that catalyzes the posttranslational conversion of arginine to citrulline (Arg -> Cit) in a number of proteins, including histories. While the gene encoding this enzyme has been implicated in the pathophysiology of rheumatoid arthritis (RA), little is known about its mechanism of catalysis, its in vivo role, or its role in the pathophysiology of RA; however, recent reports suggest that this enzyme can act as a transcriptional corepressor for the estrogen receptor. Herein, we report our initial kinetic and mechanistic characterization of human PAD4. Specifically, these studies confirm that PAD4 catalyzes the hydrolytic deimination of Arg residues to produce Cit and ammonia. The metal dependence of PAD4 has also been evaluated, and the results indicate that PAD4 activity is highly specific for calcium. Calcium activation of PAD4 catalysis exhibits positive cooperativity with K-0.5 values in the mid to high micromolar range. Evidence indicating that calcium binding causes a conformational change is also presented. Additionally, the steady-state kinetic parameters for a number of histone H4-based peptide substrates and benzoylated Arg derivatives have been determined. K-m, values for these compounds are in the high micromolar to the low millimolar range with k(cat) values ranging from 2.8 to 6.6 s(-1). The ability of PAD4 to catalyze the deimination of methylated Arg residues has also been evaluated, and the results indicate that these compounds are poor PAD4 substrates (V/K <= 31.3 M-1 s(-1)) in comparison to other substrates. These findings suggest that the full-length enzyme does not catalyze this reaction in vitro and possibly in vivo either. Collectively, the studies described herein will provide a firm foundation for the future development of PAD4 selective inhibitors.
引用
收藏
页码:10570 / 10582
页数:13
相关论文
共 61 条
[1]   Structural basis for Ca2+-induced activation of human PAD4 [J].
Arita, K ;
Hashimoto, H ;
Shimizu, T ;
Nakashima, K ;
Yamada, M ;
Sato, M .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (08) :777-783
[2]   Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V [J].
Arita, K ;
Hashimoto, H ;
Shimizu, T ;
Yamada, M ;
Sato, M .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2003, 59 :2332-2333
[3]  
Baeten D, 2001, ARTHRITIS RHEUM, V44, P2255, DOI 10.1002/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO
[4]  
2-#
[5]   Histone methylation: Dynamic or static? [J].
Bannister, AJ ;
Schneider, R ;
Kouzarides, T .
CELL, 2002, 109 (07) :801-806
[6]   A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population [J].
Barton, A ;
Bowes, J ;
Eyre, S ;
Spreckley, K ;
Hinks, A ;
John, S ;
Worthington, J .
ARTHRITIS AND RHEUMATISM, 2004, 50 (04) :1117-1121
[7]   Molecular mechanism of aminoglycoside antibiotic kinase APH(3′)-IIIa -: Roles of conserved active site residues [J].
Boehr, DD ;
Thompson, PR ;
Wright, GD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :23929-23936
[8]   A family base study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population [J].
Caponi, L ;
Petit-Teixeira, E ;
Sebbag, M ;
Bongiorni, F ;
Moscato, S ;
Pratesi, F ;
Pierlot, C ;
Osorio, J ;
Chapuy-Regaud, S ;
Guerrin, M ;
Cornelis, F ;
Serre, G ;
Migliorini, P .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) :587-593
[9]   Histone deimination antagonizes arginine methylation [J].
Cuthbert, GL ;
Daujat, S ;
Snowden, AW ;
Erdjument-Bromage, H ;
Hagiwara, T ;
Yamada, M ;
Schneider, R ;
Gregory, PD ;
Tempst, P ;
Bannister, AJ ;
Kouzarides, T .
CELL, 2004, 118 (05) :545-553
[10]   Crystal structures of arginine deiminase with covalent reaction intermediates: Implications for catalytic mechanism [J].
Das, K ;
Butler, GH ;
Kwiatkowski, V ;
Clark, AD ;
Yadav, P ;
Arnold, E .
STRUCTURE, 2004, 12 (04) :657-667